Walvax Biotechnology Revenue

In the year 2024, Walvax Biotechnology had annual revenue of 2.82B CNY, down -31.41%. Walvax Biotechnology had revenue of 680.10M in the quarter ending December 31, 2024, a decrease of -28.84%.

Revenue

2.82B

Revenue Growth

-31.41%

P/S Ratio

5.75

Revenue / Employee

1.18M

Employees

2,388

Market Cap

16.22B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.82B	-1.29B	-31.41%
Dec 31, 2023	4.11B	-972.67M	-19.12%
Jan 1, 2023	5.09B	1.62B	46.89%
Jan 1, 2022	3.46B	523.81M	17.82%
Dec 31, 2020	2.94B	1.82B	162.13%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	27.98B
Shenzhen Mindray Bio-Medical Electronics	37.11B
WuXi AppTec	37.92B
Zhangzhou Pientzehuang Pharmaceutical.,	10.91B
Aier Eye Hospital Group	20.62B
Sichuan Biokin Pharmaceutical	5.82B
Yunnan Baiyao Group Co.,Ltd	40.03B
Shanghai United Imaging Healthcare	10.30B

Revenue Rankings